Journal of Hypertension · Nov 17, 2026

Management of hypertension in older persons: what do the 2023/2024 European Society of Hypertension, 2024 European Society of Cardiology and 2025 American Heart Association/American College of Cardiology guidelines tell us?

By Gąsowski J, Piotrowicz K, Ribeiro H et al.

Treatment of hypertension in older people is associated with significant health-related benefits. However, at very old age, in patients with frailty, multimorbidity, and polypharmacy, the benefits of treatment must be balanced against the potential for harm from adverse events. The evidence for treatment in such populations is limited because they typically have not been included in many clinical trials. In this article, we discuss the differences in the approach to management of hypertension in older patients between the three recent clinical guidelines: the European Society of Hypertension (2023–2024), European Society of Cardiology (2024) and the American Heart Association/American College of Cardiology (2025) guidelines. We conclude that the therapeutic approach to older persons should be personalized and should include a comprehensive evaluation of functionality and frailty. Balancing potential health-related benefits and harms should be the basis of all clinical decisions in this population, especially for individuals eluding simplistic classifications.

doi.org/10.1097/hjh.0000000000004504Industry & policy

AgingResearch.News